A Careful, Honest Comparison

ChondroFiller® vs Stem Cell Injection

Both sit under the regenerative-medicine label, but they work differently. ChondroFiller® is a structural scaffold for cartilage formation. Stem cell injections deliver the biological material: cells and signals from bone marrow, adipose tissue or platelet-rich fibrin. Here is the honest comparison.

Illustration of ChondroFiller injected under ultrasound guidance to coat the worn cartilage surface of the knee
  1. Collagen scaffold
  2. Ultrasound-guided injection
  3. Coats the worn surface

ChondroFiller®

A collagen scaffold injected under ultrasound guidance. It sets in minutes and coats the worn cartilage so your own cells can lay down new tissue.

Illustration of concentrated cells from your own tissue injected into the knee joint
  1. Your own cells concentrated
  2. Injected into the joint
  3. Signalling, not a structure

Stem Cell Injection

Concentrated cells from your own bone marrow or fat, injected into the joint to modulate inflammation.

Quick answer

ChondroFiller® is a structural scaffold; stem cell injections add biological cells and signals. ChondroFiller® places a collagen matrix that coats the cartilage surface of the joint, with no upper age limit and no defect-size limit, so the body’s own cells can lay down new tissue over six to twelve months. Stem cell injections in UK practice typically use bone-marrow aspirate concentrate (BMAC) or fat-derived medicinal signalling cells, injected into the joint to modulate inflammation and support repair. The two are sometimes paired together; at London Cartilage Clinic that combination is delivered as the surgical Liquid Cartilage™ pathway, not as an injection.

How it works

ChondroFiller® vs Stem Cell Injection: the key difference

A stem cell injection adds cells and signalling factors into the joint environment. ChondroFiller® adds a structural scaffold inside a specific cartilage defect: a matrix that the body’s own cells can migrate into and rebuild over the following six to twelve months. The cleanest way to think about it: ChondroFiller® provides the where and what of new tissue formation; stem cell therapy provides additional who and signal. They address different parts of the same biology.

How each treatment works

ChondroFiller®

Illustration of ChondroFiller injected under ultrasound guidance to coat the worn cartilage surface of the knee

ChondroFiller® is a sterile type I collagen scaffold. At London Cartilage Clinic it is injected as a liquid into the joint under ultrasound guidance, where it sets within minutes and coats the worn cartilage at the load-bearing surfaces, from a contained focal defect to diffuse surface wear.

The patient’s own cells then migrate into the scaffold and lay down new cartilage matrix over six to twelve months. ChondroFiller® is structural and regenerative: it actually fills the defect.

Stem Cell Injection

Illustration of concentrated cells from your own tissue injected into the knee joint

Stem cell injections in UK MSK practice typically use medicinal signalling cells taken from the patient’s own bone marrow (BMAC), fat (adipose-derived) or platelet-rich fibrin. The material is concentrated at the point of care and injected into the joint, usually under ultrasound guidance.

The proposed mechanism is largely paracrine signalling: the cells release factors that modulate inflammation and recruit local cells. They do not by themselves place a structure into a defect.

Looking ahead

What can you expect over time?

ChondroFiller®

Tissue formation over 6–12 months

Published ChondroFiller® cohorts show maintained outcomes (IKDC, Harris Hip Score, MOCART MRI) at five years and beyond in suitable focal defects.

Stem Cell Injection

Variable; signal-based, often 12–24 months

Stem cell injection outcomes are heterogeneous because preparations, cell sources and doses vary widely. Reported durations range from twelve to twenty-four months of symptom benefit in selected cohorts. The repair-tissue effect on cartilage itself is less consistently demonstrated than the signalling and anti-inflammatory effect.

Read the comparison in context

Direct duration comparison is misleading: scaffold-based regeneration and signal-based cell therapy are not measured the same way. ChondroFiller® aims for durable structural tissue; most stem cell injection protocols aim primarily for symptom modulation.
Explore the ChondroFiller evidence →

Your treatment plan

Number of injections

ChondroFiller®

Typically one injection course, with the box quantity (one, two or three) decided from MRI. Single visit. The originally implanted tissue is intended to be durable.

Stem Cell Injection

Stem cell injection protocols vary widely. Some clinics offer a single injection; others recommend a series, or annual repeat. Each course involves a fresh harvest from bone marrow, fat or blood, and centre-specific protocols.

The treatment journeys

ChondroFiller® pathway

  1. 1

    Consultation first

    You meet Professor Lee and your MRI is reviewed to decide whether you are suitable and how many boxes you need.
  2. 2

    Placed in one visit

    The gel goes in as a single outpatient injection under ultrasound guidance and local anaesthetic, taking 30 to 45 minutes, and it sets within minutes.
  3. 3

    Straight home

    You go home within the hour, a brace and crutches are not needed unless your medical team specifies, and the free six-week telephone review follows.

Stem Cell Injection pathway

  1. 1

    Harvest from your own tissue

    Material is taken from your own bone marrow, fat or blood, depending on the protocol.
  2. 2

    Concentrated at the point of care

    The preparation is concentrated at the point of care.
  3. 3

    Injected into the joint

    It is injected into the joint, usually under ultrasound guidance, to modulate inflammation; some clinics offer a single injection and others a series or an annual repeat.

Care and precautions

Understanding the risks

BEFORE · DURING · AFTER

Sterile technique.
Image guidance.
Clear aftercare.

Both are outpatient injections with low overall complication rates. ChondroFiller® at London Cartilage Clinic is delivered under real-time ultrasound guidance with full sterile technique and routine IV antibiotic cover; the most serious risk is joint infection, which is rare.

Stem cell injections additionally involve a harvest step (bone marrow aspiration, fat liposuction or blood draw, depending on protocol), each with its own minor risks. UK stem cell therapy is tightly regulated under ATMP and HCT rules; ask any clinic about the regulatory basis of their preparation, the cell source and dose, and what outcome data they publish.

Practical planning and safety

Questions to raise before either option

Ask about temporary soreness or swelling, the risk of joint infection, and anything specific to your health and current medicines. Ask who you contact if something does not feel right afterwards.

Who may suit ChondroFiller →

Aftercare depends on the route

After the ChondroFiller injection there is no brace and no crutches unless your medical team specifies otherwise. Keyhole surgery follows the rehabilitation protocol set out by the manufacturer, with a brace for 48 hours and weight rebuilt over about six to eight weeks.

Read the injection aftercare guide →

Your joint, your goals

Where does each option fit?

A syringe being prepared from a blood sample
Your symptoms, scans and goals guide the decision.

ChondroFiller® works on the cartilage surface of the joint, whether the wear is a contained focal defect or diffuse across the surface. There is no upper age limit and no defect-size limit on the injection alone. It is a structural scaffold treatment that can also be combined with cells via the Liquid Cartilage™ surgical co-delivery pathway where appropriate. See who is suitable for ChondroFiller?

Stem cell injections are most often recommended for mild-to-moderate joint disease where the goal is modulating the joint environment rather than filling a defined defect, and as a supportive adjunct in some cartilage and soft-tissue protocols.

Patients who want both a scaffold and a stem-cell component in one procedure, for example with a larger defect or a more complex picture, are usually best served by the surgical Liquid Cartilage™ keyhole pathway, where ChondroFiller® and medicinal signalling cells are co-delivered through arthroscopy in a single procedure at a flat £9,800.

What would make the difference for you?

Questions worth taking to your consultation, so the discussion stays on your joint.

  1. 01What is causing my joint pain?The diagnosis and your imaging decide which treatments are worth discussing.
  2. 02Is there a defect, or wear across the joint?Ask how the pattern of cartilage damage shapes the recommendation.
  3. 03What improvement are we aiming for?Agree realistic goals for pain, function and timescale before you choose.
  4. 04What happens if I need more help later?Ask which options stay open if symptoms return or progress.
Arrange a discovery call

Planning the cost

Compare the complete care package

Ultrasound-guided injection

ChondroFiller®

From · one box

£3,000

Two boxes £5,500; three boxes £8,000. The consultation is charged separately.

Full ChondroFiller pricing →

At London Cartilage Clinic, ChondroFiller® costs from £3,000 for one box, £5,500 for two and £8,000 for three, with the consultation charged separately. See the ChondroFiller® cost guide.

Stem cell injection prices in the UK vary significantly by clinic, cell source and preparation protocol, commonly £3,000–£8,000 per course, sometimes more for branded protocols. Some clinics quote per session, others per course; ask for the total cost in writing before agreeing.

Where a patient is considering both, the surgical Liquid Cartilage™ pathway at a flat £9,800 is the London Cartilage Clinic route that delivers ChondroFiller® and medicinal signalling cells together in a single keyhole procedure. Injection-only ChondroFiller® and injection-only stem cell therapy remain separate, smaller treatments.

Making a recommendation

When each option may make sense

ChondroFiller®

A discussion to have

  • A focal cartilage defect on MRI where a regenerative scaffold can fill the space and support new tissue formation.
  • A patient who wants a defect-specific regenerative pathway rather than a signal-based joint-environment injection.
  • Cases where a stem-cell injection alone has already been tried and the underlying defect has not improved.

Stem Cell Injection

A discussion to have

  • Mild-to-moderate joint disease where modulating the joint environment is the primary goal rather than filling a defined defect.
  • A supportive adjunct in some cartilage or soft-tissue protocols, where the treating clinician has planned the role and the timing.
  • Patients exploring biologic options before committing to a structural procedure such as ChondroFiller® or surgery.

Choosing another path

When another approach may be better

ChondroFiller®

A reason to reconsider

  • Diffuse joint inflammation or early degeneration without a focal cartilage defect: another modality is likely the more appropriate first step.
  • Active infection or unwillingness to accept the conservative safety protocol.

Stem Cell Injection

A reason to reconsider

  • A patient with a clear focal cartilage defect on MRI, where a scaffold or cell-based implantation procedure is the more direct regenerative step.
  • Patients expecting a stem cell injection alone to regenerate a defined cartilage defect: the structural evidence for cell injection without a scaffold is less consistent than the symptom-modulation evidence.
  • Bundled-by-default stem-cell add-on at the time of booking. Combination treatment should be planned at consultation after imaging review, not upsold on the day.

The bottom line

ChondroFiller® and stem cell injections both sit under the regenerative-medicine label, but they work in different ways and answer different clinical questions. Where there is a defined cartilage defect to fill, ChondroFiller® is the more direct regenerative tool; where the goal is modulating the joint environment, stem cell injections may be reasonable. When both a scaffold and a stem-cell component are wanted in one procedure, that is the surgical Liquid Cartilage™ keyhole pathway, not an injection.

Common questions

01

Are stem cells the same as PRP?

No. PRP concentrates platelets and the growth factors they release; stem cell therapy delivers the cells themselves, usually medicinal signalling cells from bone marrow, fat or platelet-rich fibrin. PRP is a signal-only treatment; stem cell therapy provides cells and signals. They are sometimes used together, but they are not the same product.

02

Can I have ChondroFiller® with stem cells in the same injection?

At London Cartilage Clinic the combined scaffold-plus-cells pathway is delivered as the surgical Liquid Cartilage™ keyhole procedure at a flat £9,800, not as an injection. We deliberately do not bundle a stem cell injection into the standard ChondroFiller® injection price because the cell component is a separate clinical decision, not a default add-on.

03

Will a stem cell injection on its own regenerate my cartilage?

The honest answer is: usually not in a structural sense. Stem cell injection protocols have the strongest evidence for symptom modulation and joint-environment effects. The structural regeneration of a defined cartilage defect is harder to demonstrate from cells alone, which is why scaffolds (ChondroFiller®) or cell-based implantation procedures (MACI, ACI) are used when filling a defect is the goal.

04

How is stem cell therapy regulated in the UK?

UK stem cell therapy for joints sits under ATMP and HCT regulations. Ask any clinic about the regulatory basis of their preparation, the cell source and dose, the handling protocol and what outcome data they publish. A clinic that cannot answer these questions clearly is one to be cautious about.

05

I had a stem cell injection and it did not help. Will ChondroFiller® work?

That depends on what the imaging shows now. If a focal cartilage defect is the dominant finding, the stem cell injection alone may not have addressed it. ChondroFiller® can be a reasonable next step. We review the post-injection MRI before deciding.

06

How does the evidence compare?

Stem cell injection evidence is heterogeneous; results depend on the cell source, the preparation and the clinical setting. ChondroFiller® has cartilage-specific outcome data (IKDC, Harris Hip Score, MOCART MRI) and over 19,000 cases of clinical use across joints. See the ChondroFiller® clinical evidence page.

Book a ChondroFiller® Assessment in London

Natural cartilage regeneration starts with the right defect, the right operator, and the right plan. Start with a free call, or book a consultation with Professor Lee at our Harley Street clinic.
Privacy & Cookies PolicyTerms & ConditionsFeedback & Complaints
Free Discovery Call